Literature DB >> 29039141

Does Parkinson's disease start in the gut?

Arthur Lionnet1,2, Laurène Leclair-Visonneau2,3,4, Michel Neunlist2,3, Shigeo Murayama5, Masaki Takao6, Charles H Adler7, Pascal Derkinderen8,9,10, Thomas G Beach11.   

Abstract

Parkinson's disease (PD) is pathologically characterized by the presence of intraneuronal inclusions, termed Lewy bodies and Lewy neurites, whose main component is alpha-synuclein. Based on the topographic distribution of Lewy bodies and neurites established after autopsy from PD patients, Braak and coworkers hypothesized that PD pathology may start in the gastrointestinal tract then spread through the vagus nerve to the brain. This hypothesis has been reinforced by the discovery that alpha-synuclein may be capable of spreading transcellularly, thereby providing a mechanistic basis for Braak's hypothesis. This 'gut to brain' scenario has ignited heated debates within the movement disorders community and prompted a large number of studies in both humans and animals. Here, we review the arguments for and against the gut as the origin of PD. We conclude that the human autopsy evidence does not support the hypothesis and that it is too early to draw any definitive conclusions. We discuss how this issue might be further addressed in future research.

Entities:  

Keywords:  Alpha-synuclein; Dorsal motor nucleus of the vagus; Enteric nervous system; Gut; Parkinson’s disease; Vagus nerve

Mesh:

Year:  2017        PMID: 29039141     DOI: 10.1007/s00401-017-1777-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  57 in total

1.  Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models.

Authors:  Pablo Garrido-Gil; Ana I Rodriguez-Perez; Antonio Dominguez-Meijide; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Mol Neurobiol       Date:  2018-02-05       Impact factor: 5.590

Review 2.  The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration.

Authors:  Danielle E Mor; Malcolm J Daniels; Harry Ischiropoulos
Journal:  Mov Disord       Date:  2019-01-11       Impact factor: 10.338

Review 3.  Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.

Authors:  David K Simon; Caroline M Tanner; Patrik Brundin
Journal:  Clin Geriatr Med       Date:  2019-08-24       Impact factor: 3.076

Review 4.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

5.  Alpha-synuclein is present in dental calculus but not altered in Parkinson's disease patients in comparison to controls.

Authors:  Sabrina Schmid; Eva Goldberg-Bockhorn; Silke Schwarz; Nicole Rotter; Jan Kassubek; Kelly Del Tredici; Elmar Pinkhardt; Markus Otto; Albert C Ludolph; Patrick Oeckl
Journal:  J Neurol       Date:  2018-03-29       Impact factor: 4.849

Review 6.  Gastrointestinal dysfunction in the synucleinopathies.

Authors:  Kathryn A Chung; Ronald F Pfeiffer
Journal:  Clin Auton Res       Date:  2020-11-27       Impact factor: 4.435

7.  The vermiform appendix impacts the risk of developing Parkinson's disease.

Authors:  Bryan A Killinger; Zachary Madaj; Jacek W Sikora; Nolwen Rey; Alec J Haas; Yamini Vepa; Daniel Lindqvist; Honglei Chen; Paul M Thomas; Patrik Brundin; Lena Brundin; Viviane Labrie
Journal:  Sci Transl Med       Date:  2018-10-31       Impact factor: 17.956

Review 8.  Gastrointestinal Dysfunction in Parkinson's Disease.

Authors:  Ronald F Pfeiffer
Journal:  Curr Treat Options Neurol       Date:  2018-10-25       Impact factor: 3.598

9.  Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease.

Authors:  C Sampath; R Kalpana; T Ansah; C Charlton; A Hale; K M Channon; S Srinivasan; P R Gangula
Journal:  Dig Dis Sci       Date:  2019-06-11       Impact factor: 3.199

10.  Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.

Authors:  Zachary A Sorrentino; Ethan Hass; Niran Vijayaraghavan; Kimberly-Marie Gorion; Cara J Riffe; Jess-Karan S Dhillon; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2020-05-01       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.